Tempus AI Inc Class A Common Stock (TEM)
NASDAQ
Closed
Oct 7, 2026
Day's Range
68.6652 wk Range
40.77Overview - TEM - Tempus AI Inc Class A Common Stock
Key Statistics
Valuation
Enterprise Value
15.40B
P/E (Trailing)
‪39.29‬
P/E (Forward)
‪-9,421.18‬
PEG Ratio
‪-0.35‬
Price / Sales (TTM)
‪9.63‬
Price / Book
‪30.95‬
EV / EBITDA
‪-79.67‬
Profitability
Gross Margin
‪64.44%‬
Profit Margin
‪-17.76%‬
Operating Margin
‪-20.10%‬
Return on Assets
‪-8.54%‬
Return on Equity
‪-67.44%‬
Ownership
Shares Outstanding
180.24M
Float
116.29M
Short % of Shares Outstanding
‪27.78%‬
Held by Insiders
‪36.76%‬
Held by Institutions
‪59.27%‬
Price stats
Beta
‪3.72‬
50-Day Avg
‪61.37‬
200-Day Avg
‪56.38‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
20 analysts
Average price target
‪$ 63.36‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TEM - Tempus AI Inc Class A Common Stock
Peers - TEM - Tempus AI Inc Class A Common Stock
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
- TEMNASDAQTempus AI Inc Class A Common Stock13.82BMarket Cap-21.47%52-week change39.30P/E (Trailing)‪-17.76%‬Profit Margin
- TXGNASDAQ10x Genomics Inc. Class A Common Stock12.18BMarket Cap+86.48%52-week change-267.14P/E (Trailing)‪-12.17%‬Profit Margin
- BTSGNASDAQBrightSpring Health Services, Inc.11.92BMarket Cap+52.08%52-week change50.90P/E (Trailing)‪2.54%‬Profit Margin
- HQYNASDAQHealthEquity Inc.7.29BMarket Cap-8.03%52-week change31.86P/E (Trailing)‪17.36%‬Profit Margin
- WAYNASDAQWaystar Holding Corp.4.75BMarket Cap-54.25%52-week change35.44P/E (Trailing)‪11.17%‬Profit Margin
- HTFLNASDAQHeartFlow Inc.4.27BMarket Cap+29.84%52-week change-15.52P/E (Trailing)‪-55.81%‬Profit Margin
- PINCNASDAQPremier Inc.4.06BMarket Cap+43.27%52-week change288.91P/E (Trailing)‪73.40%‬Profit Margin
Profile Summary - TEM - Tempus AI Inc Class A Common Stock
About
Tempus AI Inc Class A Common Stock is the equity of Tempus AI, a healthcare technology company focused on applying artificial intelligence and machine learning to precision medicine. The company develops AI-enabled solutions that help physicians use clinical and molecular data to support more personalized care, while…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
